TFAM and obesity due to melanocortin 4 receptor deficiency: TFAM deletion in adipose tissue increases mitochondrial oxidation, with positive metabolic effects, suggesting regulation of adipose tissue mitochondria may be a therapeutic target for obesity treatment.